BioSpace News Archive

Aristea Therapeutics today announced that it will present at the 2nd Annual LifeSci Partners Private Company Summer Symposium.

Schrödinger, Inc. today reported that on July 15, 2021, the company granted non-statutory stock options to purchase an aggregate of 32,975 shares of the company’s common stock to 14 newly hired employees.

- Patients with iron deficiency anemia in a hospital or clinic setting now have access to an important IV iron medicine at a more affordable price

Globus Medical , Inc. will announce its financial results for the second quarter ended June 30, 2021 after the market close on Wednesday, August 4, 2021.

- Tumors use exosomes to send signals to protect the tumor, promote cancer - Exosome inhibition is a new anti-cancer class: applies to many tumors and all stages

Inspira Technologies OXY B.H.N. Ltd (the “Company”), a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology, today announced the closing of its initial public offering of 2,909,091 units at a public offering price of $5.51 per unit,

Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the closing of its previously announced underwritten public offering of 6,845,238 shares of its common stock, which includes the exercise in full by the underwriters of their option to purchase an additional 892,857 shares, at a public offering price of $42.00 per share.

Ocugen, Inc. announced the Compensation Committee of the Board of Directors of Ocugen approved the grant of stock options to purchase an aggregate of 150,750 shares of its common stock and restricted stock units covering an aggregate of 25,250 shares of common stock to seven new employees.

Aurinia Pharmaceuticals Inc., a commercial stage biopharmaceutical company advancing therapies for severe autoimmune diseases, announced it will voluntarily delist the common shares of the Company from the Toronto Stock Exchange effective as of the close of trading on July 30, 2021.

Immunofluorescence assay is a method involved in antibody-antigen reactions.